Pembrolizumab in Treating Patients With Bladder Cancer Undergoing Radical Cystectomy

NCT03319745 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

23

Enrollment

OTHER

Sponsor class

Conditions

Stage I Bladder Cancer AJCC v8
Stage II Bladder Cancer AJCC v8
Stage III Bladder Cancer AJCC v8
Stage IIIA Bladder Cancer AJCC v8
Stage IIIB Bladder Cancer AJCC v8

Interventions

BIOLOGICAL: Pembrolizumab

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]